CIK 0001609809
- Non-accelerated filer
- Smaller reporting company
Seres Therapeutics, Inc.
Sign in to watch- Ticker
- MCRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 274326290
- Phone
- +1 617-945-9626
- Business address
- 200 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- Seres Therapeutics, Inc., Seres Health, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $795
- in 4 filings, $795 under 10b5-1 plans
Net −$795. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 39 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-06-30 | Shaff Eric D. CFO and EVP | Sale | −4,533 | $29.54 | $134K | 0 |
| 2016-06-30 | Shaff Eric D. CFO and EVP | Exercise or conversion · Stock Option (right to buy) | −4,533 | 233,454 | ||
| 2016-06-28 | Shaff Eric D. CFO and EVP | Exercise or conversion | +1,667 | $7.79 | $13K | 1,667 |
| 2016-06-28 | Shaff Eric D. CFO and EVP | Sale | −1,667 | $28.85 | $48K | 0 |
| 2016-06-28 | Shaff Eric D. CFO and EVP | Exercise or conversion · Stock Option (right to buy) | −1,667 | 237,987 | ||
| 2016-06-27 | Aunins John G. Chief Technology Officer & EVP | Sale | −9,390 | $27.23 | $256K | 32,655 |
| 2016-06-27 | Shaff Eric D. CFO and EVP | Exercise or conversion | +3,334 | $7.79 | $26K | 3,334 |
| 2016-06-27 | Shaff Eric D. CFO and EVP | Sale | −3,334 | $28.00 | $93K | 0 |
| 2016-06-27 | Shaff Eric D. CFO and EVP | Exercise or conversion · Stock Option (right to buy) | −3,334 | 239,654 | ||
| 2016-06-15 | Kim Lorence H. Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2016-06-15 | Graves Kurt Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2016-06-15 | Kender Richard N Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2016-06-15 | Ausiello Dennis A Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2016-06-15 | AFEYAN NOUBAR Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2016-06-15 | HUTT PETER BARTON Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2016-06-02 | Pomerantz Roger President and CEO | Exercise or conversion | +74,049 | $0.71 | $53K | 257,741 |
| 2016-06-02 | Pomerantz Roger President and CEO | Sale | −6,583 | $31.62 | $208K | 251,158 |
| 2016-06-02 | Pomerantz Roger President and CEO | Sale | −47,159 | $32.34 | $1.5M | 203,999 |
| 2016-06-02 | Pomerantz Roger President and CEO | Sale | −20,307 | $33.22 | $675K | 183,692 |
| 2016-06-02 | Pomerantz Roger President and CEO | Exercise or conversion · Stock Option (right to buy) | −74,049 | 1,217,286 |
Page 33 of 34 · 662 trades